GPN Vaccines

Canberra, Australia · Founded 2017 · Privately Held (backing)

Developer of vaccines intended to offer protection against pneumococcal bacteria, the world's foremost bacterial pathogen. GPN Vaccines is based in Canberra, Australia and was founded in 2017. Its last reported valuation was $300 million in Jun 2024. It has raised $27.7 million across 1 recorded round; the latest was a $3.5 million seed round in Dec 2025.

Last reported valuation
$300.0M
Oct 2026
Priced at
—
Total raised
$27.7M
Last round
Seed Round
Dec 2025
How much has GPN Vaccines raised?
$27.7Macross 1 recorded rounds · Dec 2025 – Dec 2025

Most recently, GPN Vaccines raised $3.5M in its Seed Round (Dec 2025).

Free account
More of GPN Vaccines with a free account
  • ·Watch GPN Vaccines: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

GPN Vaccines round by round

1 rounds
Dec 2025Seed Round$3.5MSEC filing▮
63 investors participated

How much has GPN Vaccines raised?

GPN Vaccines has raised $27.7 million in total; 1 of its rounds is on record. The largest on record was a $3.5 million seed round in Dec 2025.

GPN Vaccines has filed 1 Form D with the SEC, most recently in Jan 2026 ($3.5 million sold to 63 investors).

GPN Vaccines investors

7 investors are on record for GPN Vaccines, including Shearwater Capital, Brandon Biocatalyst, Forepont Capital Partners and Kern Capital. The seed round in Dec 2025 drew 63 investors.

For fundraisers
Raising for a company like GPN Vaccines?

7 investors have backed GPN Vaccines.

See all 7 investors →

Frequently asked about GPN Vaccines

How much has GPN Vaccines raised?
GPN Vaccines has raised $27.7M in total across 1 recorded funding rounds.
When was GPN Vaccines's last funding round?
GPN Vaccines's most recent recorded round was Seed Round in Dec 2025, raising $3.5M.